home / stock / scph / scph message board
Subject | By | Source | When |
---|---|---|---|
scPharmaceuticals Inc. discloses that it has two deposit | FooBarAndGrill | investorshub | 03/12/2023 3:15:26 AM |
$SCPH PR: | FooBarAndGrill | investorshub | 02/21/2023 3:57:27 PM |
Monday 20th is Go-To-Market. | FooBarAndGrill | investorshub | 02/17/2023 5:01:55 PM |
$SCPH provides business updates. | FooBarAndGrill | investorshub | 01/30/2023 4:44:21 PM |
Will $SCPH ever sell a single dose of | FooBarAndGrill | investorshub | 01/24/2023 2:29:10 AM |
The go-to-market for the Furoscix infusor/drug combo is | FooBarAndGrill | investorshub | 01/16/2023 3:43:01 PM |
Furoscix administered via the Furoscix Infusor. | FooBarAndGrill | investorshub | 12/28/2022 9:26:50 PM |
$SCPH Prescription Drug product FUROSCIX has been added | FooBarAndGrill | investorshub | 12/19/2022 4:48:00 PM |
$SCPH Prescription Drug product FUROSCIX has been added | FooBarAndGrill | investorshub | 12/08/2022 3:27:29 PM |
PDUFA! Approval! | FooBarAndGrill | investorshub | 10/10/2022 12:43:22 PM |
PDUFA! Approval! | FooBarAndGrill | investorshub | 10/10/2022 12:43:14 PM |
PDUFA After Market today? | FooBarAndGrill | investorshub | 10/07/2022 3:48:56 PM |
Whats up here today | akamaii | investorshub | 04/17/2019 12:34:09 PM |
News, Short Squeeze, Breakout and More Instantly...
scPharmaceuticals Inc. Company Name:
SCPH Stock Symbol:
NASDAQ Market:
scPharmaceuticals Inc. Website:
Generated 1Q 2024 net FUROSCIX ® revenue of $6.1 million, despite an estimated 10% impact to doses filled resulting from the Change Healthcare cyberattack Ended 1Q 2024 with cash and cash equivalents o f $58.4 million Company to host investor conference call and web...
BURLINGTON, Mass., May 13, 2024 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (NASDAQ:SCPH), a pharmaceutical company focused on developing and com...
BURLINGTON, Mass., May 13, 2024 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, today an...